business
informative
impactful
Novo Nordisk cuts U.S. prices of diabetes and weight-loss drugs by half
Feb 24, 2026, 2:47 PM10
(Update: Feb 24, 2026, 2:47 PM)
business
informative
impactful
Novo Nordisk cuts U.S. prices of diabetes and weight-loss drugs by half
- Novo Nordisk will reduce list prices of Ozempic and Wegovy by up to 50% starting January 1, 2027.
- The price reductions will align with new pricing regulations for federal Medicare health plans.
- This decision demonstrates the company’s commitment to enhancing drug affordability in a competitive healthcare market.
Insights
News 1 1
Related reports
Opinions
Story
“
shift policy global data economic geopolitical trends insight geopolitical data shift analysis trends insight economic data data strategic market geopolitical shift impact insight analysis market policy geopolitical strategic shift trends market trends economic global shift analysis policy data strategic data insight shift strategic strategic strategic economic market geopolitical impact geopolitical data data market insight policy market global trends strategic insight policy trends strategic impact policy insight strategic analysis analysis shift analysis global policy data market impact analysis data impact global...
2026 All rights reserved
2026 All rights reserved